id	sid	tid	token	lemma	pos
cord-329363-kaw3h5xm	1	1	key	key	JJ
cord-329363-kaw3h5xm	1	2	:	:	:
cord-329363-kaw3h5xm	1	3	cord-329363-kaw3h5xm	cord-329363-kaw3h5xm	NNS
cord-329363-kaw3h5xm	1	4	authors	author	NNS
cord-329363-kaw3h5xm	1	5	:	:	:
cord-329363-kaw3h5xm	1	6	Vardeny	Vardeny	NNP
cord-329363-kaw3h5xm	1	7	,	,	,
cord-329363-kaw3h5xm	1	8	Orly	Orly	NNP
cord-329363-kaw3h5xm	1	9	;	;	:
cord-329363-kaw3h5xm	1	10	Madjid	Madjid	NNP
cord-329363-kaw3h5xm	1	11	,	,	,
cord-329363-kaw3h5xm	1	12	Mohammad	Mohammad	NNP
cord-329363-kaw3h5xm	1	13	;	;	:
cord-329363-kaw3h5xm	1	14	Solomon	Solomon	NNP
cord-329363-kaw3h5xm	1	15	,	,	,
cord-329363-kaw3h5xm	1	16	Scott	Scott	NNP
cord-329363-kaw3h5xm	1	17	D.	D.	NNP
cord-329363-kaw3h5xm	1	18	title	title	NN
cord-329363-kaw3h5xm	1	19	:	:	:
cord-329363-kaw3h5xm	2	1	Applying	apply	VBG
cord-329363-kaw3h5xm	2	2	the	the	DT
cord-329363-kaw3h5xm	2	3	Lessons	Lessons	NNPS
cord-329363-kaw3h5xm	2	4	of	of	IN
cord-329363-kaw3h5xm	2	5	Influenza	Influenza	NNP
cord-329363-kaw3h5xm	2	6	to	to	TO
cord-329363-kaw3h5xm	2	7	COVID-19	covid-19	VB
cord-329363-kaw3h5xm	2	8	During	during	IN
cord-329363-kaw3h5xm	2	9	a	a	DT
cord-329363-kaw3h5xm	2	10	Time	Time	NNP
cord-329363-kaw3h5xm	2	11	of	of	IN
cord-329363-kaw3h5xm	2	12	Uncertainty	Uncertainty	NNP
cord-329363-kaw3h5xm	2	13	date	date	NN
cord-329363-kaw3h5xm	2	14	:	:	:
cord-329363-kaw3h5xm	2	15	2020	2020	CD
cord-329363-kaw3h5xm	2	16	-	-	HYPH
cord-329363-kaw3h5xm	2	17	05	05	CD
cord-329363-kaw3h5xm	2	18	-	-	SYM
cord-329363-kaw3h5xm	2	19	26	26	CD
cord-329363-kaw3h5xm	2	20	journal	journal	NN
cord-329363-kaw3h5xm	2	21	:	:	:
cord-329363-kaw3h5xm	3	1	Circulation	circulation	NN
cord-329363-kaw3h5xm	3	2	DOI	doi	NN
cord-329363-kaw3h5xm	3	3	:	:	:
cord-329363-kaw3h5xm	3	4	10.1161	10.1161	CD
cord-329363-kaw3h5xm	3	5	/	/	SYM
cord-329363-kaw3h5xm	3	6	circulationaha.120.046837	circulationaha.120.046837	NN
cord-329363-kaw3h5xm	3	7	sha	sha	NNP
cord-329363-kaw3h5xm	3	8	:	:	:
cord-329363-kaw3h5xm	3	9	83a6fc8a59aa7f469fbe2094129bc2143e76b762	83a6fc8a59aa7f469fbe2094129bc2143e76b762	CD
cord-329363-kaw3h5xm	3	10	doc_id	doc_id	CD
cord-329363-kaw3h5xm	3	11	:	:	:
cord-329363-kaw3h5xm	3	12	329363	329363	CD
cord-329363-kaw3h5xm	3	13	cord_uid	cord_uid	NN
cord-329363-kaw3h5xm	3	14	:	:	:
cord-329363-kaw3h5xm	4	1	kaw3h5xm	kaw3h5xm	NNP
cord-329363-kaw3h5xm	4	2	nan	nan	NNP
cord-329363-kaw3h5xm	4	3	dysfunction	dysfunction	NN
cord-329363-kaw3h5xm	4	4	and	and	CC
cord-329363-kaw3h5xm	4	5	inflammation	inflammation	NN
cord-329363-kaw3h5xm	4	6	,	,	,
cord-329363-kaw3h5xm	4	7	which	which	WDT
cord-329363-kaw3h5xm	4	8	can	can	MD
cord-329363-kaw3h5xm	4	9	attenuate	attenuate	VB
cord-329363-kaw3h5xm	4	10	innate	innate	JJ
cord-329363-kaw3h5xm	4	11	immune	immune	JJ
cord-329363-kaw3h5xm	4	12	function	function	NN
cord-329363-kaw3h5xm	4	13	.	.	.
cord-329363-kaw3h5xm	5	1	Immune	immune	JJ
cord-329363-kaw3h5xm	5	2	dysregulation	dysregulation	NN
cord-329363-kaw3h5xm	5	3	and	and	CC
cord-329363-kaw3h5xm	5	4	cytokine	cytokine	NN
cord-329363-kaw3h5xm	5	5	storm	storm	NN
cord-329363-kaw3h5xm	5	6	appear	appear	VBP
cord-329363-kaw3h5xm	5	7	to	to	TO
cord-329363-kaw3h5xm	5	8	be	be	VB
cord-329363-kaw3h5xm	5	9	key	key	JJ
cord-329363-kaw3h5xm	5	10	components	component	NNS
cord-329363-kaw3h5xm	5	11	of	of	IN
cord-329363-kaw3h5xm	5	12	progression	progression	NN
cord-329363-kaw3h5xm	5	13	to	to	IN
cord-329363-kaw3h5xm	5	14	critical	critical	JJ
cord-329363-kaw3h5xm	5	15	disease	disease	NN
cord-329363-kaw3h5xm	5	16	in	in	IN
cord-329363-kaw3h5xm	5	17	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	5	18	.	.	.
cord-329363-kaw3h5xm	6	1	Individuals	individual	NNS
cord-329363-kaw3h5xm	6	2	with	with	IN
cord-329363-kaw3h5xm	6	3	heart	heart	NN
cord-329363-kaw3h5xm	6	4	failure	failure	NN
cord-329363-kaw3h5xm	6	5	exhibit	exhibit	NN
cord-329363-kaw3h5xm	6	6	attenuated	attenuated	JJ
cord-329363-kaw3h5xm	6	7	immune	immune	JJ
cord-329363-kaw3h5xm	6	8	response	response	NN
cord-329363-kaw3h5xm	6	9	to	to	IN
cord-329363-kaw3h5xm	6	10	influenza	influenza	NN
cord-329363-kaw3h5xm	6	11	viruses	virus	NNS
cord-329363-kaw3h5xm	6	12	and	and	CC
cord-329363-kaw3h5xm	6	13	most	most	RBS
cord-329363-kaw3h5xm	6	14	certainly	certainly	RB
cord-329363-kaw3h5xm	6	15	will	will	MD
cord-329363-kaw3h5xm	6	16	have	have	VB
cord-329363-kaw3h5xm	6	17	similar	similar	JJ
cord-329363-kaw3h5xm	6	18	altered	alter	VBN
cord-329363-kaw3h5xm	6	19	immune	immune	JJ
cord-329363-kaw3h5xm	6	20	responses	response	NNS
cord-329363-kaw3h5xm	6	21	to	to	IN
cord-329363-kaw3h5xm	6	22	COVID-19	covid-19	VB
cord-329363-kaw3h5xm	6	23	.	.	.
cord-329363-kaw3h5xm	7	1	Even	even	RB
cord-329363-kaw3h5xm	7	2	among	among	IN
cord-329363-kaw3h5xm	7	3	those	those	DT
cord-329363-kaw3h5xm	7	4	without	without	IN
cord-329363-kaw3h5xm	7	5	underlying	underlie	VBG
cord-329363-kaw3h5xm	7	6	cardiac	cardiac	JJ
cord-329363-kaw3h5xm	7	7	disease	disease	NN
cord-329363-kaw3h5xm	7	8	,	,	,
cord-329363-kaw3h5xm	7	9	the	the	DT
cord-329363-kaw3h5xm	7	10	prior	prior	JJ
cord-329363-kaw3h5xm	7	11	coronavirus	coronavirus	NN
cord-329363-kaw3h5xm	7	12	outbreaks	outbreak	NNS
cord-329363-kaw3h5xm	7	13	have	have	VBP
cord-329363-kaw3h5xm	7	14	been	be	VBN
cord-329363-kaw3h5xm	7	15	associated	associate	VBN
cord-329363-kaw3h5xm	7	16	with	with	IN
cord-329363-kaw3h5xm	7	17	adverse	adverse	JJ
cord-329363-kaw3h5xm	7	18	cardiovascular	cardiovascular	JJ
cord-329363-kaw3h5xm	7	19	effects	effect	NNS
cord-329363-kaw3h5xm	7	20	.	.	.
cord-329363-kaw3h5xm	8	1	Both	both	DT
cord-329363-kaw3h5xm	8	2	transient	transient	JJ
cord-329363-kaw3h5xm	8	3	cardiomegaly	cardiomegaly	NN
cord-329363-kaw3h5xm	8	4	and	and	CC
cord-329363-kaw3h5xm	8	5	decreases	decrease	NNS
cord-329363-kaw3h5xm	8	6	in	in	IN
cord-329363-kaw3h5xm	8	7	left	left	JJ
cord-329363-kaw3h5xm	8	8	ventricular	ventricular	JJ
cord-329363-kaw3h5xm	8	9	ejection	ejection	NN
cord-329363-kaw3h5xm	8	10	fraction	fraction	NN
cord-329363-kaw3h5xm	8	11	,	,	,
cord-329363-kaw3h5xm	8	12	observed	observe	VBD
cord-329363-kaw3h5xm	8	13	during	during	IN
cord-329363-kaw3h5xm	8	14	acute	acute	JJ
cord-329363-kaw3h5xm	8	15	illness	illness	NN
cord-329363-kaw3h5xm	8	16	with	with	IN
cord-329363-kaw3h5xm	8	17	improvement	improvement	NN
cord-329363-kaw3h5xm	8	18	after	after	IN
cord-329363-kaw3h5xm	8	19	recovery	recovery	NN
cord-329363-kaw3h5xm	8	20	,	,	,
cord-329363-kaw3h5xm	8	21	were	be	VBD
cord-329363-kaw3h5xm	8	22	reported	report	VBN
cord-329363-kaw3h5xm	8	23	during	during	IN
cord-329363-kaw3h5xm	8	24	the	the	DT
cord-329363-kaw3h5xm	8	25	2002	2002	CD
cord-329363-kaw3h5xm	8	26	to	to	IN
cord-329363-kaw3h5xm	8	27	2003	2003	CD
cord-329363-kaw3h5xm	8	28	severe	severe	JJ
cord-329363-kaw3h5xm	8	29	acute	acute	JJ
cord-329363-kaw3h5xm	8	30	respiratory	respiratory	JJ
cord-329363-kaw3h5xm	8	31	syndrome	syndrome	NN
cord-329363-kaw3h5xm	8	32	(	(	-LRB-
cord-329363-kaw3h5xm	8	33	SARS	SARS	NNP
cord-329363-kaw3h5xm	8	34	)	)	-RRB-
cord-329363-kaw3h5xm	8	35	epidemic	epidemic	NN
cord-329363-kaw3h5xm	8	36	.	.	.
cord-329363-kaw3h5xm	9	1	SARS	SARS	NNP
cord-329363-kaw3h5xm	9	2	coronavirus	coronavirus	NN
cord-329363-kaw3h5xm	9	3	2	2	CD
cord-329363-kaw3h5xm	10	1	(	(	-LRB-
cord-329363-kaw3h5xm	10	2	SARS	SARS	NNP
cord-329363-kaw3h5xm	10	3	-	-	HYPH
cord-329363-kaw3h5xm	10	4	CoV-2	CoV-2	NNP
cord-329363-kaw3h5xm	10	5	)	)	-RRB-
cord-329363-kaw3h5xm	10	6	shares	share	VBZ
cord-329363-kaw3h5xm	10	7	79.5	79.5	CD
cord-329363-kaw3h5xm	10	8	%	%	NN
cord-329363-kaw3h5xm	10	9	sequence	sequence	NN
cord-329363-kaw3h5xm	10	10	identity	identity	NN
cord-329363-kaw3h5xm	10	11	with	with	IN
cord-329363-kaw3h5xm	10	12	SARS	SARS	NNP
cord-329363-kaw3h5xm	10	13	coronavirus	coronavirus	NN
cord-329363-kaw3h5xm	10	14	(	(	-LRB-
cord-329363-kaw3h5xm	10	15	SARS	SARS	NNP
cord-329363-kaw3h5xm	10	16	-	-	HYPH
cord-329363-kaw3h5xm	10	17	CoV	CoV	NNP
cord-329363-kaw3h5xm	10	18	)	)	-RRB-
cord-329363-kaw3h5xm	10	19	,	,	,
cord-329363-kaw3h5xm	10	20	and	and	CC
cord-329363-kaw3h5xm	10	21	the	the	DT
cord-329363-kaw3h5xm	10	22	point	point	NN
cord-329363-kaw3h5xm	10	23	of	of	IN
cord-329363-kaw3h5xm	10	24	entry	entry	NN
cord-329363-kaw3h5xm	10	25	of	of	IN
cord-329363-kaw3h5xm	10	26	SARS	SARS	NNP
cord-329363-kaw3h5xm	10	27	-	-	HYPH
cord-329363-kaw3h5xm	10	28	CoV-2	CoV-2	NNP
cord-329363-kaw3h5xm	10	29	into	into	IN
cord-329363-kaw3h5xm	10	30	the	the	DT
cord-329363-kaw3h5xm	10	31	host	host	NN
cord-329363-kaw3h5xm	10	32	cell	cell	NN
cord-329363-kaw3h5xm	10	33	is	be	VBZ
cord-329363-kaw3h5xm	10	34	also	also	RB
cord-329363-kaw3h5xm	10	35	analogous	analogous	JJ
cord-329363-kaw3h5xm	10	36	to	to	IN
cord-329363-kaw3h5xm	10	37	SARS	SARS	NNP
cord-329363-kaw3h5xm	10	38	-	-	HYPH
cord-329363-kaw3h5xm	10	39	CoV	CoV	NNP
cord-329363-kaw3h5xm	10	40	,	,	,
cord-329363-kaw3h5xm	10	41	through	through	IN
cord-329363-kaw3h5xm	10	42	the	the	DT
cord-329363-kaw3h5xm	10	43	angiotensin	angiotensin	NN
cord-329363-kaw3h5xm	10	44	-	-	HYPH
cord-329363-kaw3h5xm	10	45	converting	convert	VBG
cord-329363-kaw3h5xm	10	46	enzyme	enzyme	NN
cord-329363-kaw3h5xm	10	47	2	2	CD
cord-329363-kaw3h5xm	10	48	receptor	receptor	NN
cord-329363-kaw3h5xm	10	49	,	,	,
cord-329363-kaw3h5xm	10	50	which	which	WDT
cord-329363-kaw3h5xm	10	51	is	be	VBZ
cord-329363-kaw3h5xm	10	52	expressed	express	VBN
cord-329363-kaw3h5xm	10	53	on	on	IN
cord-329363-kaw3h5xm	10	54	airway	airway	JJ
cord-329363-kaw3h5xm	10	55	epithelial	epithelial	JJ
cord-329363-kaw3h5xm	10	56	cells	cell	NNS
cord-329363-kaw3h5xm	10	57	.	.	.
cord-329363-kaw3h5xm	11	1	Whereas	whereas	IN
cord-329363-kaw3h5xm	11	2	the	the	DT
cord-329363-kaw3h5xm	11	3	majority	majority	NN
cord-329363-kaw3h5xm	11	4	of	of	IN
cord-329363-kaw3h5xm	11	5	severe	severe	JJ
cord-329363-kaw3h5xm	11	6	morbidity	morbidity	NN
cord-329363-kaw3h5xm	11	7	associated	associate	VBN
cord-329363-kaw3h5xm	11	8	with	with	IN
cord-329363-kaw3h5xm	11	9	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	11	10	has	have	VBZ
cord-329363-kaw3h5xm	11	11	been	be	VBN
cord-329363-kaw3h5xm	11	12	pulmonary	pulmonary	JJ
cord-329363-kaw3h5xm	11	13	,	,	,
cord-329363-kaw3h5xm	11	14	reports	report	NNS
cord-329363-kaw3h5xm	11	15	are	be	VBP
cord-329363-kaw3h5xm	11	16	emerging	emerge	VBG
cord-329363-kaw3h5xm	11	17	of	of	IN
cord-329363-kaw3h5xm	11	18	cardiac	cardiac	JJ
cord-329363-kaw3h5xm	11	19	injury	injury	NN
cord-329363-kaw3h5xm	11	20	,	,	,
cord-329363-kaw3h5xm	11	21	left	leave	VBD
cord-329363-kaw3h5xm	11	22	ventricular	ventricular	JJ
cord-329363-kaw3h5xm	11	23	dysfunction	dysfunction	NN
cord-329363-kaw3h5xm	11	24	,	,	,
cord-329363-kaw3h5xm	11	25	and	and	CC
cord-329363-kaw3h5xm	11	26	myocarditis	myocarditis	NN
cord-329363-kaw3h5xm	11	27	associated	associate	VBN
cord-329363-kaw3h5xm	11	28	with	with	IN
cord-329363-kaw3h5xm	11	29	severe	severe	JJ
cord-329363-kaw3h5xm	11	30	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	11	31	,	,	,
cord-329363-kaw3h5xm	11	32	4	4	CD
cord-329363-kaw3h5xm	11	33	and	and	CC
cord-329363-kaw3h5xm	11	34	the	the	DT
cord-329363-kaw3h5xm	11	35	molecular	molecular	JJ
cord-329363-kaw3h5xm	11	36	similarities	similarity	NNS
cord-329363-kaw3h5xm	11	37	of	of	IN
cord-329363-kaw3h5xm	11	38	SARS	SARS	NNP
cord-329363-kaw3h5xm	11	39	-	-	HYPH
cord-329363-kaw3h5xm	11	40	CoV-2	CoV-2	NNP
cord-329363-kaw3h5xm	11	41	and	and	CC
cord-329363-kaw3h5xm	11	42	SARS	SARS	NNP
cord-329363-kaw3h5xm	11	43	-	-	HYPH
cord-329363-kaw3h5xm	11	44	CoV	CoV	NNP
cord-329363-kaw3h5xm	12	1	make	make	VB
cord-329363-kaw3h5xm	12	2	cardiac	cardiac	JJ
cord-329363-kaw3h5xm	12	3	effects	effect	NNS
cord-329363-kaw3h5xm	12	4	similar	similar	JJ
cord-329363-kaw3h5xm	12	5	to	to	IN
cord-329363-kaw3h5xm	12	6	those	those	DT
cord-329363-kaw3h5xm	12	7	reported	report	VBN
cord-329363-kaw3h5xm	12	8	with	with	IN
cord-329363-kaw3h5xm	12	9	SARS	SARS	NNP
cord-329363-kaw3h5xm	12	10	likely	likely	JJ
cord-329363-kaw3h5xm	12	11	.	.	.
cord-329363-kaw3h5xm	13	1	Whereas	whereas	IN
cord-329363-kaw3h5xm	13	2	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	13	3	shares	share	NNS
cord-329363-kaw3h5xm	13	4	similarities	similarity	NNS
cord-329363-kaw3h5xm	13	5	with	with	IN
cord-329363-kaw3h5xm	13	6	seasonal	seasonal	JJ
cord-329363-kaw3h5xm	13	7	influenza	influenza	NN
cord-329363-kaw3h5xm	13	8	,	,	,
cord-329363-kaw3h5xm	13	9	it	-PRON-	PRP
cord-329363-kaw3h5xm	13	10	appears	appear	VBZ
cord-329363-kaw3h5xm	13	11	to	to	TO
cord-329363-kaw3h5xm	13	12	be	be	VB
cord-329363-kaw3h5xm	13	13	more	more	RBR
cord-329363-kaw3h5xm	13	14	transmissible	transmissible	JJ
cord-329363-kaw3h5xm	13	15	and	and	CC
cord-329363-kaw3h5xm	13	16	more	more	RBR
cord-329363-kaw3h5xm	13	17	virulent	virulent	JJ
cord-329363-kaw3h5xm	13	18	than	than	IN
cord-329363-kaw3h5xm	13	19	any	any	DT
cord-329363-kaw3h5xm	13	20	influenza	influenza	NN
cord-329363-kaw3h5xm	13	21	since	since	IN
cord-329363-kaw3h5xm	13	22	the	the	DT
cord-329363-kaw3h5xm	13	23	1918	1918	CD
cord-329363-kaw3h5xm	13	24	influenza	influenza	NN
cord-329363-kaw3h5xm	13	25	pandemic	pandemic	NN
cord-329363-kaw3h5xm	13	26	.	.	.
cord-329363-kaw3h5xm	14	1	Estimates	estimate	NNS
cord-329363-kaw3h5xm	14	2	from	from	IN
cord-329363-kaw3h5xm	14	3	China	China	NNP
cord-329363-kaw3h5xm	14	4	indicate	indicate	VBP
cord-329363-kaw3h5xm	14	5	that	that	IN
cord-329363-kaw3h5xm	14	6	the	the	DT
cord-329363-kaw3h5xm	14	7	COVID-19	covid-19	JJ
cord-329363-kaw3h5xm	14	8	basic	basic	JJ
cord-329363-kaw3h5xm	14	9	reproductive	reproductive	JJ
cord-329363-kaw3h5xm	14	10	number	number	NN
cord-329363-kaw3h5xm	14	11	(	(	-LRB-
cord-329363-kaw3h5xm	14	12	secondary	secondary	JJ
cord-329363-kaw3h5xm	14	13	cases	case	NNS
cord-329363-kaw3h5xm	14	14	generated	generate	VBN
cord-329363-kaw3h5xm	14	15	by	by	IN
cord-329363-kaw3h5xm	14	16	a	a	DT
cord-329363-kaw3h5xm	14	17	primary	primary	JJ
cord-329363-kaw3h5xm	14	18	case	case	NN
cord-329363-kaw3h5xm	14	19	of	of	IN
cord-329363-kaw3h5xm	14	20	infection	infection	NN
cord-329363-kaw3h5xm	14	21	in	in	IN
cord-329363-kaw3h5xm	14	22	a	a	DT
cord-329363-kaw3h5xm	14	23	susceptible	susceptible	JJ
cord-329363-kaw3h5xm	14	24	population	population	NN
cord-329363-kaw3h5xm	14	25	)	)	-RRB-
cord-329363-kaw3h5xm	14	26	is	be	VBZ
cord-329363-kaw3h5xm	14	27	≈1.94	≈1.94	NNP
cord-329363-kaw3h5xm	14	28	,	,	,
cord-329363-kaw3h5xm	14	29	which	which	WDT
cord-329363-kaw3h5xm	14	30	is	be	VBZ
cord-329363-kaw3h5xm	14	31	higher	high	JJR
cord-329363-kaw3h5xm	14	32	than	than	IN
cord-329363-kaw3h5xm	14	33	that	that	DT
cord-329363-kaw3h5xm	14	34	of	of	IN
cord-329363-kaw3h5xm	14	35	influenza	influenza	NN
cord-329363-kaw3h5xm	14	36	,	,	,
cord-329363-kaw3h5xm	14	37	estimated	estimate	VBN
cord-329363-kaw3h5xm	14	38	at	at	IN
cord-329363-kaw3h5xm	14	39	1.3	1.3	CD
cord-329363-kaw3h5xm	14	40	for	for	IN
cord-329363-kaw3h5xm	14	41	most	most	JJS
cord-329363-kaw3h5xm	14	42	years	year	NNS
cord-329363-kaw3h5xm	14	43	and	and	CC
cord-329363-kaw3h5xm	14	44	1.8	1.8	CD
cord-329363-kaw3h5xm	14	45	for	for	IN
cord-329363-kaw3h5xm	14	46	the	the	DT
cord-329363-kaw3h5xm	14	47	1918	1918	CD
cord-329363-kaw3h5xm	14	48	influenza	influenza	NN
cord-329363-kaw3h5xm	14	49	pandemic	pandemic	NN
cord-329363-kaw3h5xm	14	50	.	.	.
cord-329363-kaw3h5xm	15	1	Accumulating	accumulate	VBG
cord-329363-kaw3h5xm	15	2	data	datum	NNS
cord-329363-kaw3h5xm	15	3	indicate	indicate	VBP
cord-329363-kaw3h5xm	15	4	higher	high	JJR
cord-329363-kaw3h5xm	15	5	mortality	mortality	NN
cord-329363-kaw3h5xm	15	6	rates	rate	NNS
cord-329363-kaw3h5xm	15	7	for	for	IN
cord-329363-kaw3h5xm	15	8	COVID-19	covid-19	NN
cord-329363-kaw3h5xm	15	9	compared	compare	VBN
cord-329363-kaw3h5xm	15	10	with	with	IN
cord-329363-kaw3h5xm	15	11	the	the	DT
cord-329363-kaw3h5xm	15	12	2009	2009	CD
cord-329363-kaw3h5xm	15	13	H1N1	H1N1	NNP
cord-329363-kaw3h5xm	15	14	pandemic	pandemic	NN
cord-329363-kaw3h5xm	15	15	.	.	.
cord-329363-kaw3h5xm	16	1	Although	although	IN
cord-329363-kaw3h5xm	16	2	most	most	JJS
cord-329363-kaw3h5xm	16	3	individuals	individual	NNS
cord-329363-kaw3h5xm	16	4	with	with	IN
cord-329363-kaw3h5xm	16	5	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	16	6	do	do	VBP
cord-329363-kaw3h5xm	16	7	not	not	RB
cord-329363-kaw3h5xm	16	8	experience	experience	VB
cord-329363-kaw3h5xm	16	9	severe	severe	JJ
cord-329363-kaw3h5xm	16	10	symptoms	symptom	NNS
cord-329363-kaw3h5xm	16	11	,	,	,
cord-329363-kaw3h5xm	16	12	evidence	evidence	NN
cord-329363-kaw3h5xm	16	13	of	of	IN
cord-329363-kaw3h5xm	16	14	asymptomatic	asymptomatic	JJ
cord-329363-kaw3h5xm	16	15	transmission	transmission	NN
cord-329363-kaw3h5xm	16	16	and	and	CC
cord-329363-kaw3h5xm	16	17	substantial	substantial	JJ
cord-329363-kaw3h5xm	16	18	community	community	NN
cord-329363-kaw3h5xm	16	19	spread	spread	VBN
cord-329363-kaw3h5xm	16	20	suggest	suggest	VBP
cord-329363-kaw3h5xm	16	21	that	that	IN
cord-329363-kaw3h5xm	16	22	this	this	DT
cord-329363-kaw3h5xm	16	23	virus	virus	NN
cord-329363-kaw3h5xm	16	24	will	will	MD
cord-329363-kaw3h5xm	16	25	infect	infect	VB
cord-329363-kaw3h5xm	16	26	a	a	DT
cord-329363-kaw3h5xm	16	27	larger	large	JJR
cord-329363-kaw3h5xm	16	28	number	number	NN
cord-329363-kaw3h5xm	16	29	of	of	IN
cord-329363-kaw3h5xm	16	30	people	people	NNS
cord-329363-kaw3h5xm	16	31	and	and	CC
cord-329363-kaw3h5xm	16	32	lead	lead	VB
cord-329363-kaw3h5xm	16	33	to	to	IN
cord-329363-kaw3h5xm	16	34	more	more	JJR
cord-329363-kaw3h5xm	16	35	deaths	death	NNS
cord-329363-kaw3h5xm	16	36	than	than	IN
cord-329363-kaw3h5xm	16	37	SARS	SARS	NNP
cord-329363-kaw3h5xm	16	38	and	and	CC
cord-329363-kaw3h5xm	16	39	Middle	Middle	NNP
cord-329363-kaw3h5xm	16	40	East	East	NNP
cord-329363-kaw3h5xm	16	41	respiratory	respiratory	JJ
cord-329363-kaw3h5xm	16	42	syndrome	syndrome	NN
cord-329363-kaw3h5xm	16	43	.	.	.
cord-329363-kaw3h5xm	17	1	5	5	LS
cord-329363-kaw3h5xm	17	2	Current	current	JJ
cord-329363-kaw3h5xm	17	3	strategies	strategy	NNS
cord-329363-kaw3h5xm	17	4	for	for	IN
cord-329363-kaw3h5xm	17	5	COVID-19	covid-19	JJ
cord-329363-kaw3h5xm	17	6	management	management	NN
cord-329363-kaw3h5xm	17	7	focus	focus	NN
cord-329363-kaw3h5xm	17	8	on	on	IN
cord-329363-kaw3h5xm	17	9	minimizing	minimize	VBG
cord-329363-kaw3h5xm	17	10	transmission	transmission	NN
cord-329363-kaw3h5xm	17	11	and	and	CC
cord-329363-kaw3h5xm	17	12	spread	spread	NN
cord-329363-kaw3h5xm	17	13	of	of	IN
cord-329363-kaw3h5xm	17	14	infection	infection	NN
cord-329363-kaw3h5xm	17	15	and	and	CC
cord-329363-kaw3h5xm	17	16	providing	provide	VBG
cord-329363-kaw3h5xm	17	17	supportive	supportive	JJ
cord-329363-kaw3h5xm	17	18	care	care	NN
cord-329363-kaw3h5xm	17	19	for	for	IN
cord-329363-kaw3h5xm	17	20	individuals	individual	NNS
cord-329363-kaw3h5xm	17	21	who	who	WP
cord-329363-kaw3h5xm	17	22	experience	experience	VBP
cord-329363-kaw3h5xm	17	23	airway	airway	NN
cord-329363-kaw3h5xm	17	24	compromise	compromise	NN
cord-329363-kaw3h5xm	17	25	or	or	CC
cord-329363-kaw3h5xm	17	26	other	other	JJ
cord-329363-kaw3h5xm	17	27	adverse	adverse	JJ
cord-329363-kaw3h5xm	17	28	clinical	clinical	JJ
cord-329363-kaw3h5xm	17	29	sequelae	sequela	NNS
cord-329363-kaw3h5xm	17	30	.	.	.
cord-329363-kaw3h5xm	18	1	Because	because	IN
cord-329363-kaw3h5xm	18	2	severity	severity	NN
cord-329363-kaw3h5xm	18	3	of	of	IN
cord-329363-kaw3h5xm	18	4	illness	illness	NN
cord-329363-kaw3h5xm	18	5	with	with	IN
cord-329363-kaw3h5xm	18	6	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	18	7	can	can	MD
cord-329363-kaw3h5xm	18	8	be	be	VB
cord-329363-kaw3h5xm	18	9	highly	highly	RB
cord-329363-kaw3h5xm	18	10	variable	variable	JJ
cord-329363-kaw3h5xm	18	11	,	,	,
cord-329363-kaw3h5xm	18	12	with	with	IN
cord-329363-kaw3h5xm	18	13	some	some	DT
cord-329363-kaw3h5xm	18	14	individuals	individual	NNS
cord-329363-kaw3h5xm	18	15	displaying	display	VBG
cord-329363-kaw3h5xm	18	16	no	no	DT
cord-329363-kaw3h5xm	18	17	or	or	CC
cord-329363-kaw3h5xm	18	18	minimal	minimal	JJ
cord-329363-kaw3h5xm	18	19	symptoms	symptom	NNS
cord-329363-kaw3h5xm	18	20	,	,	,
cord-329363-kaw3h5xm	18	21	and	and	CC
cord-329363-kaw3h5xm	18	22	with	with	IN
cord-329363-kaw3h5xm	18	23	restricted	restricted	JJ
cord-329363-kaw3h5xm	18	24	testing	testing	NN
cord-329363-kaw3h5xm	18	25	available	available	JJ
cord-329363-kaw3h5xm	18	26	in	in	IN
cord-329363-kaw3h5xm	18	27	most	most	JJS
cord-329363-kaw3h5xm	18	28	places	place	NNS
cord-329363-kaw3h5xm	18	29	,	,	,
cord-329363-kaw3h5xm	18	30	individuals	individual	NNS
cord-329363-kaw3h5xm	18	31	at	at	IN
cord-329363-kaw3h5xm	18	32	high	high	JJ
cord-329363-kaw3h5xm	18	33	risk	risk	NN
cord-329363-kaw3h5xm	18	34	should	should	MD
cord-329363-kaw3h5xm	18	35	avoid	avoid	VB
cord-329363-kaw3h5xm	18	36	contact	contact	NN
cord-329363-kaw3h5xm	18	37	with	with	IN
cord-329363-kaw3h5xm	18	38	people	people	NNS
cord-329363-kaw3h5xm	18	39	with	with	IN
cord-329363-kaw3h5xm	18	40	even	even	RB
cord-329363-kaw3h5xm	18	41	mild	mild	JJ
cord-329363-kaw3h5xm	18	42	respiratory	respiratory	JJ
cord-329363-kaw3h5xm	18	43	infections	infection	NNS
cord-329363-kaw3h5xm	18	44	.	.	.
cord-329363-kaw3h5xm	19	1	Other	other	JJ
cord-329363-kaw3h5xm	19	2	strategies	strategy	NNS
cord-329363-kaw3h5xm	19	3	for	for	IN
cord-329363-kaw3h5xm	19	4	minimizing	minimize	VBG
cord-329363-kaw3h5xm	19	5	risk	risk	NN
cord-329363-kaw3h5xm	19	6	of	of	IN
cord-329363-kaw3h5xm	19	7	exposure	exposure	NN
cord-329363-kaw3h5xm	19	8	include	include	VBP
cord-329363-kaw3h5xm	19	9	delaying	delay	VBG
cord-329363-kaw3h5xm	19	10	routine	routine	NN
cord-329363-kaw3h5xm	19	11	,	,	,
cord-329363-kaw3h5xm	19	12	in	in	IN
cord-329363-kaw3h5xm	19	13	-	-	HYPH
cord-329363-kaw3h5xm	19	14	person	person	NN
cord-329363-kaw3h5xm	19	15	medical	medical	JJ
cord-329363-kaw3h5xm	19	16	appointments	appointment	NNS
cord-329363-kaw3h5xm	19	17	and	and	CC
cord-329363-kaw3h5xm	19	18	elective	elective	JJ
cord-329363-kaw3h5xm	19	19	procedures	procedure	NNS
cord-329363-kaw3h5xm	19	20	.	.	.
cord-329363-kaw3h5xm	20	1	In	in	IN
cord-329363-kaw3h5xm	20	2	the	the	DT
cord-329363-kaw3h5xm	20	3	absence	absence	NN
cord-329363-kaw3h5xm	20	4	of	of	IN
cord-329363-kaw3h5xm	20	5	an	an	DT
cord-329363-kaw3h5xm	20	6	effective	effective	JJ
cord-329363-kaw3h5xm	20	7	vaccine	vaccine	NN
cord-329363-kaw3h5xm	20	8	or	or	CC
cord-329363-kaw3h5xm	20	9	targeted	target	VBN
cord-329363-kaw3h5xm	20	10	antiviral	antiviral	JJ
cord-329363-kaw3h5xm	20	11	therapies	therapy	NNS
cord-329363-kaw3h5xm	20	12	,	,	,
cord-329363-kaw3h5xm	20	13	management	management	NN
cord-329363-kaw3h5xm	20	14	options	option	NNS
cord-329363-kaw3h5xm	20	15	are	be	VBP
cord-329363-kaw3h5xm	20	16	limited	limited	JJ
cord-329363-kaw3h5xm	20	17	.	.	.
cord-329363-kaw3h5xm	21	1	Several	several	JJ
cord-329363-kaw3h5xm	21	2	pharmacological	pharmacological	JJ
cord-329363-kaw3h5xm	21	3	treatments	treatment	NNS
cord-329363-kaw3h5xm	21	4	are	be	VBP
cord-329363-kaw3h5xm	21	5	under	under	IN
cord-329363-kaw3h5xm	21	6	investigation	investigation	NN
cord-329363-kaw3h5xm	21	7	,	,	,
cord-329363-kaw3h5xm	21	8	and	and	CC
cord-329363-kaw3h5xm	21	9	we	-PRON-	PRP
cord-329363-kaw3h5xm	21	10	need	need	VBP
cord-329363-kaw3h5xm	21	11	to	to	TO
cord-329363-kaw3h5xm	21	12	be	be	VB
cord-329363-kaw3h5xm	21	13	vigilant	vigilant	JJ
cord-329363-kaw3h5xm	21	14	in	in	IN
cord-329363-kaw3h5xm	21	15	considering	consider	VBG
cord-329363-kaw3h5xm	21	16	how	how	WRB
cord-329363-kaw3h5xm	21	17	they	-PRON-	PRP
cord-329363-kaw3h5xm	21	18	may	may	MD
cord-329363-kaw3h5xm	21	19	affect	affect	VB
cord-329363-kaw3h5xm	21	20	the	the	DT
cord-329363-kaw3h5xm	21	21	cardiovascular	cardiovascular	JJ
cord-329363-kaw3h5xm	21	22	system	system	NN
cord-329363-kaw3h5xm	21	23	.	.	.
cord-329363-kaw3h5xm	22	1	For	for	IN
cord-329363-kaw3h5xm	22	2	example	example	NN
cord-329363-kaw3h5xm	22	3	,	,	,
cord-329363-kaw3h5xm	22	4	use	use	NN
cord-329363-kaw3h5xm	22	5	of	of	IN
cord-329363-kaw3h5xm	22	6	chloroquine	chloroquine	NN
cord-329363-kaw3h5xm	22	7	and	and	CC
cord-329363-kaw3h5xm	22	8	hydroxychloroquine	hydroxychloroquine	NNP
cord-329363-kaw3h5xm	22	9	,	,	,
cord-329363-kaw3h5xm	22	10	for	for	IN
cord-329363-kaw3h5xm	22	11	which	which	WDT
cord-329363-kaw3h5xm	22	12	limited	limited	JJ
cord-329363-kaw3h5xm	22	13	data	datum	NNS
cord-329363-kaw3h5xm	22	14	exist	exist	VBP
cord-329363-kaw3h5xm	22	15	,	,	,
cord-329363-kaw3h5xm	22	16	can	can	MD
cord-329363-kaw3h5xm	22	17	cause	cause	VB
cord-329363-kaw3h5xm	22	18	QT	QT	NNP
cord-329363-kaw3h5xm	22	19	prolongation	prolongation	NN
cord-329363-kaw3h5xm	22	20	.	.	.
cord-329363-kaw3h5xm	23	1	For	for	IN
cord-329363-kaw3h5xm	23	2	patients	patient	NNS
cord-329363-kaw3h5xm	23	3	with	with	IN
cord-329363-kaw3h5xm	23	4	underlying	underlying	JJ
cord-329363-kaw3h5xm	23	5	cardiovascular	cardiovascular	JJ
cord-329363-kaw3h5xm	23	6	disease	disease	NN
cord-329363-kaw3h5xm	23	7	,	,	,
cord-329363-kaw3h5xm	23	8	other	other	JJ
cord-329363-kaw3h5xm	23	9	opportunities	opportunity	NNS
cord-329363-kaw3h5xm	23	10	for	for	IN
cord-329363-kaw3h5xm	23	11	minimizing	minimize	VBG
cord-329363-kaw3h5xm	23	12	complications	complication	NNS
cord-329363-kaw3h5xm	23	13	from	from	IN
cord-329363-kaw3h5xm	23	14	infection	infection	NN
cord-329363-kaw3h5xm	23	15	include	include	VBP
cord-329363-kaw3h5xm	23	16	remaining	remain	VBG
cord-329363-kaw3h5xm	23	17	up	up	IN
cord-329363-kaw3h5xm	23	18	to	to	IN
cord-329363-kaw3h5xm	23	19	date	date	NN
cord-329363-kaw3h5xm	23	20	on	on	IN
cord-329363-kaw3h5xm	23	21	other	other	JJ
cord-329363-kaw3h5xm	23	22	immunizations	immunization	NNS
cord-329363-kaw3h5xm	23	23	,	,	,
cord-329363-kaw3h5xm	23	24	including	include	VBG
cord-329363-kaw3h5xm	23	25	influenza	influenza	NN
cord-329363-kaw3h5xm	23	26	vaccine	vaccine	NN
cord-329363-kaw3h5xm	23	27	,	,	,
cord-329363-kaw3h5xm	23	28	which	which	WDT
cord-329363-kaw3h5xm	23	29	is	be	VBZ
cord-329363-kaw3h5xm	23	30	available	available	JJ
cord-329363-kaw3h5xm	23	31	and	and	CC
cord-329363-kaw3h5xm	23	32	effective	effective	JJ
cord-329363-kaw3h5xm	23	33	,	,	,
cord-329363-kaw3h5xm	23	34	and	and	CC
cord-329363-kaw3h5xm	23	35	pneumococcal	pneumococcal	JJ
cord-329363-kaw3h5xm	23	36	vaccine	vaccine	NN
cord-329363-kaw3h5xm	23	37	,	,	,
cord-329363-kaw3h5xm	23	38	as	as	IN
cord-329363-kaw3h5xm	23	39	secondary	secondary	JJ
cord-329363-kaw3h5xm	23	40	bacterial	bacterial	JJ
cord-329363-kaw3h5xm	23	41	infections	infection	NNS
cord-329363-kaw3h5xm	23	42	often	often	RB
cord-329363-kaw3h5xm	23	43	lead	lead	VBP
cord-329363-kaw3h5xm	23	44	to	to	IN
cord-329363-kaw3h5xm	23	45	hospitalizations	hospitalization	NNS
cord-329363-kaw3h5xm	23	46	among	among	IN
cord-329363-kaw3h5xm	23	47	those	those	DT
cord-329363-kaw3h5xm	23	48	with	with	IN
cord-329363-kaw3h5xm	23	49	primary	primary	JJ
cord-329363-kaw3h5xm	23	50	viral	viral	JJ
cord-329363-kaw3h5xm	23	51	infections	infection	NNS
cord-329363-kaw3h5xm	23	52	.	.	.
cord-329363-kaw3h5xm	24	1	Because	because	IN
cord-329363-kaw3h5xm	24	2	viral	viral	JJ
cord-329363-kaw3h5xm	24	3	illness	illness	NN
cord-329363-kaw3h5xm	24	4	has	have	VBZ
cord-329363-kaw3h5xm	24	5	been	be	VBN
cord-329363-kaw3h5xm	24	6	shown	show	VBN
cord-329363-kaw3h5xm	24	7	to	to	TO
cord-329363-kaw3h5xm	24	8	exacerbate	exacerbate	VB
cord-329363-kaw3h5xm	24	9	underlying	underlie	VBG
cord-329363-kaw3h5xm	24	10	cardiac	cardiac	JJ
cord-329363-kaw3h5xm	24	11	illness	illness	NN
cord-329363-kaw3h5xm	24	12	and	and	CC
cord-329363-kaw3h5xm	24	13	can	can	MD
cord-329363-kaw3h5xm	24	14	lead	lead	VB
cord-329363-kaw3h5xm	24	15	to	to	IN
cord-329363-kaw3h5xm	24	16	acute	acute	JJ
cord-329363-kaw3h5xm	24	17	events	event	NNS
cord-329363-kaw3h5xm	24	18	such	such	JJ
cord-329363-kaw3h5xm	24	19	as	as	IN
cord-329363-kaw3h5xm	24	20	acute	acute	JJ
cord-329363-kaw3h5xm	24	21	myocardial	myocardial	JJ
cord-329363-kaw3h5xm	24	22	infarction	infarction	NN
cord-329363-kaw3h5xm	24	23	or	or	CC
cord-329363-kaw3h5xm	24	24	decompensated	decompensate	VBN
cord-329363-kaw3h5xm	24	25	heart	heart	NN
cord-329363-kaw3h5xm	24	26	failure	failure	NN
cord-329363-kaw3h5xm	24	27	,	,	,
cord-329363-kaw3h5xm	24	28	efforts	effort	NNS
cord-329363-kaw3h5xm	24	29	should	should	MD
cord-329363-kaw3h5xm	24	30	be	be	VB
cord-329363-kaw3h5xm	24	31	made	make	VBN
cord-329363-kaw3h5xm	24	32	to	to	TO
cord-329363-kaw3h5xm	24	33	optimize	optimize	VB
cord-329363-kaw3h5xm	24	34	guideline	guideline	NN
cord-329363-kaw3h5xm	24	35	-	-	HYPH
cord-329363-kaw3h5xm	24	36	directed	direct	VBN
cord-329363-kaw3h5xm	24	37	treatment	treatment	NN
cord-329363-kaw3h5xm	24	38	strategies	strategy	NNS
cord-329363-kaw3h5xm	24	39	that	that	WDT
cord-329363-kaw3h5xm	24	40	have	have	VBP
cord-329363-kaw3h5xm	24	41	been	be	VBN
cord-329363-kaw3h5xm	24	42	shown	show	VBN
cord-329363-kaw3h5xm	24	43	to	to	TO
cord-329363-kaw3h5xm	24	44	improve	improve	VB
cord-329363-kaw3h5xm	24	45	clinical	clinical	JJ
cord-329363-kaw3h5xm	24	46	status	status	NN
cord-329363-kaw3h5xm	24	47	in	in	IN
cord-329363-kaw3h5xm	24	48	high	high	JJ
cord-329363-kaw3h5xm	24	49	-	-	HYPH
cord-329363-kaw3h5xm	24	50	risk	risk	NN
cord-329363-kaw3h5xm	24	51	patients	patient	NNS
cord-329363-kaw3h5xm	24	52	,	,	,
cord-329363-kaw3h5xm	24	53	and	and	CC
cord-329363-kaw3h5xm	24	54	thus	thus	RB
cord-329363-kaw3h5xm	24	55	reduce	reduce	VB
cord-329363-kaw3h5xm	24	56	the	the	DT
cord-329363-kaw3h5xm	24	57	risk	risk	NN
cord-329363-kaw3h5xm	24	58	of	of	IN
cord-329363-kaw3h5xm	24	59	worsening	worsen	VBG
cord-329363-kaw3h5xm	24	60	symptoms	symptom	NNS
cord-329363-kaw3h5xm	24	61	or	or	CC
cord-329363-kaw3h5xm	24	62	acute	acute	JJ
cord-329363-kaw3h5xm	24	63	events	event	NNS
cord-329363-kaw3h5xm	24	64	in	in	IN
cord-329363-kaw3h5xm	24	65	case	case	NN
cord-329363-kaw3h5xm	24	66	of	of	IN
cord-329363-kaw3h5xm	24	67	infection	infection	NN
cord-329363-kaw3h5xm	24	68	.	.	.
cord-329363-kaw3h5xm	25	1	In	in	IN
cord-329363-kaw3h5xm	25	2	patients	patient	NNS
cord-329363-kaw3h5xm	25	3	without	without	IN
cord-329363-kaw3h5xm	25	4	known	know	VBN
cord-329363-kaw3h5xm	25	5	or	or	CC
cord-329363-kaw3h5xm	25	6	suspected	suspect	VBN
cord-329363-kaw3h5xm	25	7	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	25	8	,	,	,
cord-329363-kaw3h5xm	25	9	this	this	DT
cord-329363-kaw3h5xm	25	10	includes	include	VBZ
cord-329363-kaw3h5xm	25	11	all	all	DT
cord-329363-kaw3h5xm	25	12	evidence	evidence	NN
cord-329363-kaw3h5xm	25	13	-	-	HYPH
cord-329363-kaw3h5xm	25	14	based	base	VBN
cord-329363-kaw3h5xm	25	15	therapies	therapy	NNS
cord-329363-kaw3h5xm	25	16	in	in	IN
cord-329363-kaw3h5xm	25	17	cardiovascular	cardiovascular	JJ
cord-329363-kaw3h5xm	25	18	disease	disease	NN
cord-329363-kaw3h5xm	25	19	,	,	,
cord-329363-kaw3h5xm	25	20	such	such	JJ
cord-329363-kaw3h5xm	25	21	as	as	IN
cord-329363-kaw3h5xm	25	22	aspirin	aspirin	NN
cord-329363-kaw3h5xm	25	23	,	,	,
cord-329363-kaw3h5xm	25	24	statins	statin	NNS
cord-329363-kaw3h5xm	25	25	,	,	,
cord-329363-kaw3h5xm	25	26	and	and	CC
cord-329363-kaw3h5xm	25	27	β	β	NN
cord-329363-kaw3h5xm	25	28	-	-	HYPH
cord-329363-kaw3h5xm	25	29	blockers	blocker	NNS
cord-329363-kaw3h5xm	25	30	for	for	IN
cord-329363-kaw3h5xm	25	31	secondary	secondary	JJ
cord-329363-kaw3h5xm	25	32	prevention	prevention	NN
cord-329363-kaw3h5xm	25	33	in	in	IN
cord-329363-kaw3h5xm	25	34	patients	patient	NNS
cord-329363-kaw3h5xm	25	35	with	with	IN
cord-329363-kaw3h5xm	25	36	coronary	coronary	JJ
cord-329363-kaw3h5xm	25	37	disease	disease	NN
cord-329363-kaw3h5xm	25	38	,	,	,
cord-329363-kaw3h5xm	25	39	and	and	CC
cord-329363-kaw3h5xm	25	40	guideline	guideline	NN
cord-329363-kaw3h5xm	25	41	-	-	HYPH
cord-329363-kaw3h5xm	25	42	directed	direct	VBN
cord-329363-kaw3h5xm	25	43	medical	medical	JJ
cord-329363-kaw3h5xm	25	44	therapy	therapy	NN
cord-329363-kaw3h5xm	25	45	in	in	IN
cord-329363-kaw3h5xm	25	46	those	those	DT
cord-329363-kaw3h5xm	25	47	with	with	IN
cord-329363-kaw3h5xm	25	48	heart	heart	NN
cord-329363-kaw3h5xm	25	49	failure	failure	NN
cord-329363-kaw3h5xm	25	50	.	.	.
cord-329363-kaw3h5xm	26	1	Keeping	keep	VBG
cord-329363-kaw3h5xm	26	2	patients	patient	NNS
cord-329363-kaw3h5xm	26	3	out	out	IN
cord-329363-kaw3h5xm	26	4	of	of	IN
cord-329363-kaw3h5xm	26	5	the	the	DT
cord-329363-kaw3h5xm	26	6	hospital	hospital	NN
cord-329363-kaw3h5xm	26	7	is	be	VBZ
cord-329363-kaw3h5xm	26	8	an	an	DT
cord-329363-kaw3h5xm	26	9	essential	essential	JJ
cord-329363-kaw3h5xm	26	10	component	component	NN
cord-329363-kaw3h5xm	26	11	to	to	IN
cord-329363-kaw3h5xm	26	12	reducing	reduce	VBG
cord-329363-kaw3h5xm	26	13	infection	infection	NN
cord-329363-kaw3h5xm	26	14	.	.	.
cord-329363-kaw3h5xm	27	1	The	the	DT
cord-329363-kaw3h5xm	27	2	use	use	NN
cord-329363-kaw3h5xm	27	3	of	of	IN
cord-329363-kaw3h5xm	27	4	guideline	guideline	NN
cord-329363-kaw3h5xm	27	5	-	-	HYPH
cord-329363-kaw3h5xm	27	6	directed	direct	VBN
cord-329363-kaw3h5xm	27	7	medical	medical	JJ
cord-329363-kaw3h5xm	27	8	therapy	therapy	NN
cord-329363-kaw3h5xm	27	9	is	be	VBZ
cord-329363-kaw3h5xm	27	10	also	also	RB
cord-329363-kaw3h5xm	27	11	warranted	warrant	VBN
cord-329363-kaw3h5xm	27	12	in	in	IN
cord-329363-kaw3h5xm	27	13	patients	patient	NNS
cord-329363-kaw3h5xm	27	14	with	with	IN
cord-329363-kaw3h5xm	27	15	known	know	VBN
cord-329363-kaw3h5xm	27	16	or	or	CC
cord-329363-kaw3h5xm	27	17	suspected	suspect	VBN
cord-329363-kaw3h5xm	27	18	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	27	19	.	.	.
cord-329363-kaw3h5xm	28	1	One	one	CD
cord-329363-kaw3h5xm	28	2	area	area	NN
cord-329363-kaw3h5xm	28	3	of	of	IN
cord-329363-kaw3h5xm	28	4	uncertainty	uncertainty	NN
cord-329363-kaw3h5xm	28	5	is	be	VBZ
cord-329363-kaw3h5xm	28	6	the	the	DT
cord-329363-kaw3h5xm	28	7	influence	influence	NN
cord-329363-kaw3h5xm	28	8	of	of	IN
cord-329363-kaw3h5xm	28	9	angiotensin	angiotensin	NN
cord-329363-kaw3h5xm	28	10	receptor	receptor	NN
cord-329363-kaw3h5xm	28	11	enzyme	enzyme	NN
cord-329363-kaw3h5xm	28	12	inhibitors	inhibitor	NNS
cord-329363-kaw3h5xm	28	13	and	and	CC
cord-329363-kaw3h5xm	28	14	angiotensin	angiotensin	NN
cord-329363-kaw3h5xm	28	15	receptor	receptor	NN
cord-329363-kaw3h5xm	28	16	blockers	blocker	NNS
cord-329363-kaw3h5xm	28	17	on	on	IN
cord-329363-kaw3h5xm	28	18	this	this	DT
cord-329363-kaw3h5xm	28	19	disease	disease	NN
cord-329363-kaw3h5xm	28	20	,	,	,
cord-329363-kaw3h5xm	28	21	because	because	IN
cord-329363-kaw3h5xm	28	22	coronaviruses	coronaviruse	NNS
cord-329363-kaw3h5xm	28	23	gain	gain	VBP
cord-329363-kaw3h5xm	28	24	entrance	entrance	NN
cord-329363-kaw3h5xm	28	25	to	to	IN
cord-329363-kaw3h5xm	28	26	cells	cell	NNS
cord-329363-kaw3h5xm	28	27	by	by	IN
cord-329363-kaw3h5xm	28	28	the	the	DT
cord-329363-kaw3h5xm	28	29	angiotensin	angiotensin	NN
cord-329363-kaw3h5xm	28	30	-	-	HYPH
cord-329363-kaw3h5xm	28	31	converting	convert	VBG
cord-329363-kaw3h5xm	28	32	enzyme	enzyme	NN
cord-329363-kaw3h5xm	28	33	2	2	CD
cord-329363-kaw3h5xm	28	34	receptor	receptor	NN
cord-329363-kaw3h5xm	28	35	,	,	,
cord-329363-kaw3h5xm	28	36	which	which	WDT
cord-329363-kaw3h5xm	28	37	might	may	MD
cord-329363-kaw3h5xm	28	38	be	be	VB
cord-329363-kaw3h5xm	28	39	upregulated	upregulate	VBN
cord-329363-kaw3h5xm	28	40	by	by	IN
cord-329363-kaw3h5xm	28	41	use	use	NN
cord-329363-kaw3h5xm	28	42	of	of	IN
cord-329363-kaw3h5xm	28	43	these	these	DT
cord-329363-kaw3h5xm	28	44	therapies	therapy	NNS
cord-329363-kaw3h5xm	28	45	.	.	.
cord-329363-kaw3h5xm	29	1	The	the	DT
cord-329363-kaw3h5xm	29	2	American	American	NNP
cord-329363-kaw3h5xm	29	3	Heart	Heart	NNP
cord-329363-kaw3h5xm	29	4	Association	Association	NNP
cord-329363-kaw3h5xm	29	5	,	,	,
cord-329363-kaw3h5xm	29	6	the	the	DT
cord-329363-kaw3h5xm	29	7	American	American	NNP
cord-329363-kaw3h5xm	29	8	College	College	NNP
cord-329363-kaw3h5xm	29	9	of	of	IN
cord-329363-kaw3h5xm	29	10	Cardiology	Cardiology	NNP
cord-329363-kaw3h5xm	29	11	,	,	,
cord-329363-kaw3h5xm	29	12	the	the	DT
cord-329363-kaw3h5xm	29	13	Heart	Heart	NNP
cord-329363-kaw3h5xm	29	14	Failure	Failure	NNP
cord-329363-kaw3h5xm	29	15	Society	Society	NNP
cord-329363-kaw3h5xm	29	16	of	of	IN
cord-329363-kaw3h5xm	29	17	America	America	NNP
cord-329363-kaw3h5xm	29	18	,	,	,
cord-329363-kaw3h5xm	29	19	and	and	CC
cord-329363-kaw3h5xm	29	20	the	the	DT
cord-329363-kaw3h5xm	29	21	European	European	NNP
cord-329363-kaw3h5xm	29	22	Society	Society	NNP
cord-329363-kaw3h5xm	29	23	of	of	IN
cord-329363-kaw3h5xm	29	24	Cardiology	Cardiology	NNP
cord-329363-kaw3h5xm	29	25	recommend	recommend	VBP
cord-329363-kaw3h5xm	29	26	not	not	RB
cord-329363-kaw3h5xm	29	27	withdrawing	withdraw	VBG
cord-329363-kaw3h5xm	29	28	renin	renin	NN
cord-329363-kaw3h5xm	29	29	-	-	HYPH
cord-329363-kaw3h5xm	29	30	angiotensin	angiotensin	NN
cord-329363-kaw3h5xm	29	31	system	system	NN
cord-329363-kaw3h5xm	29	32	inhibitors	inhibitor	NNS
cord-329363-kaw3h5xm	29	33	on	on	IN
cord-329363-kaw3h5xm	29	34	the	the	DT
cord-329363-kaw3h5xm	29	35	basis	basis	NN
cord-329363-kaw3h5xm	29	36	of	of	IN
cord-329363-kaw3h5xm	29	37	the	the	DT
cord-329363-kaw3h5xm	29	38	available	available	JJ
cord-329363-kaw3h5xm	29	39	data	datum	NNS
cord-329363-kaw3h5xm	29	40	unless	unless	IN
cord-329363-kaw3h5xm	29	41	warranted	warrant	VBN
cord-329363-kaw3h5xm	29	42	clinically	clinically	RB
cord-329363-kaw3h5xm	29	43	.	.	.
cord-329363-kaw3h5xm	30	1	The	the	DT
cord-329363-kaw3h5xm	30	2	rapid	rapid	JJ
cord-329363-kaw3h5xm	30	3	spread	spread	NN
cord-329363-kaw3h5xm	30	4	of	of	IN
cord-329363-kaw3h5xm	30	5	COVID-19	covid-19	NN
cord-329363-kaw3h5xm	30	6	is	be	VBZ
cord-329363-kaw3h5xm	30	7	testing	test	VBG
cord-329363-kaw3h5xm	30	8	healthcare	healthcare	NN
cord-329363-kaw3h5xm	30	9	systems	system	NNS
cord-329363-kaw3h5xm	30	10	around	around	IN
cord-329363-kaw3h5xm	30	11	the	the	DT
cord-329363-kaw3h5xm	30	12	world	world	NN
cord-329363-kaw3h5xm	30	13	profoundly	profoundly	RB
cord-329363-kaw3h5xm	30	14	and	and	CC
cord-329363-kaw3h5xm	30	15	likely	likely	RB
cord-329363-kaw3h5xm	30	16	will	will	MD
cord-329363-kaw3h5xm	30	17	continue	continue	VB
cord-329363-kaw3h5xm	30	18	to	to	TO
cord-329363-kaw3h5xm	30	19	do	do	VB
cord-329363-kaw3h5xm	30	20	so	so	RB
cord-329363-kaw3h5xm	30	21	before	before	IN
cord-329363-kaw3h5xm	30	22	this	this	DT
cord-329363-kaw3h5xm	30	23	pandemic	pandemic	NN
cord-329363-kaw3h5xm	30	24	abates	abate	VBZ
cord-329363-kaw3h5xm	30	25	.	.	.
cord-329363-kaw3h5xm	31	1	The	the	DT
cord-329363-kaw3h5xm	31	2	increased	increase	VBN
cord-329363-kaw3h5xm	31	3	vulnerability	vulnerability	NN
cord-329363-kaw3h5xm	31	4	of	of	IN
cord-329363-kaw3h5xm	31	5	patients	patient	NNS
cord-329363-kaw3h5xm	31	6	with	with	IN
cord-329363-kaw3h5xm	31	7	cardiovascular	cardiovascular	JJ
cord-329363-kaw3h5xm	31	8	disease	disease	NN
cord-329363-kaw3h5xm	31	9	at	at	IN
cord-329363-kaw3h5xm	31	10	risk	risk	NN
cord-329363-kaw3h5xm	31	11	for	for	IN
cord-329363-kaw3h5xm	31	12	adverse	adverse	JJ
cord-329363-kaw3h5xm	31	13	cardiovascular	cardiovascular	JJ
cord-329363-kaw3h5xm	31	14	outcomes	outcome	NNS
cord-329363-kaw3h5xm	31	15	,	,	,
cord-329363-kaw3h5xm	31	16	in	in	IN
cord-329363-kaw3h5xm	31	17	conjunction	conjunction	NN
cord-329363-kaw3h5xm	31	18	with	with	IN
cord-329363-kaw3h5xm	31	19	patients	patient	NNS
cord-329363-kaw3h5xm	31	20	'	'	POS
cord-329363-kaw3h5xm	31	21	reduced	reduce	VBN
cord-329363-kaw3h5xm	31	22	access	access	NN
cord-329363-kaw3h5xm	31	23	to	to	IN
cord-329363-kaw3h5xm	31	24	healthcare	healthcare	NN
cord-329363-kaw3h5xm	31	25	services	service	NNS
cord-329363-kaw3h5xm	31	26	while	while	IN
cord-329363-kaw3h5xm	31	27	the	the	DT
cord-329363-kaw3h5xm	31	28	healthcare	healthcare	NN
cord-329363-kaw3h5xm	31	29	system	system	NN
cord-329363-kaw3h5xm	31	30	is	be	VBZ
cord-329363-kaw3h5xm	31	31	stressed	stress	VBN
cord-329363-kaw3h5xm	31	32	,	,	,
cord-329363-kaw3h5xm	31	33	underscores	underscore	VBZ
cord-329363-kaw3h5xm	31	34	the	the	DT
cord-329363-kaw3h5xm	31	35	importance	importance	NN
cord-329363-kaw3h5xm	31	36	of	of	IN
cord-329363-kaw3h5xm	31	37	understanding	understand	VBG
cord-329363-kaw3h5xm	31	38	COV	COV	NNP
cord-329363-kaw3h5xm	31	39	-	-	HYPH
cord-329363-kaw3h5xm	31	40	ID-19	ID-19	NNP
cord-329363-kaw3h5xm	31	41	and	and	CC
cord-329363-kaw3h5xm	31	42	its	-PRON-	PRP$
cord-329363-kaw3h5xm	31	43	implications	implication	NNS
cord-329363-kaw3h5xm	31	44	for	for	IN
cord-329363-kaw3h5xm	31	45	all	all	DT
cord-329363-kaw3h5xm	31	46	practitioners	practitioner	NNS
cord-329363-kaw3h5xm	31	47	of	of	IN
cord-329363-kaw3h5xm	31	48	cardiovascular	cardiovascular	JJ
cord-329363-kaw3h5xm	31	49	medicine	medicine	NN
cord-329363-kaw3h5xm	31	50	.	.	.
cord-329363-kaw3h5xm	32	1	Orly	Orly	NNP
cord-329363-kaw3h5xm	32	2	Vardeny	Vardeny	NNP
cord-329363-kaw3h5xm	32	3	,	,	,
cord-329363-kaw3h5xm	32	4	PharmD	PharmD	NNP
cord-329363-kaw3h5xm	32	5	,	,	,
cord-329363-kaw3h5xm	32	6	MS	MS	NNP
cord-329363-kaw3h5xm	32	7	,	,	,
cord-329363-kaw3h5xm	32	8	Associate	Associate	NNP
cord-329363-kaw3h5xm	32	9	Professor	Professor	NNP
cord-329363-kaw3h5xm	32	10	of	of	IN
cord-329363-kaw3h5xm	32	11	Medicine	Medicine	NNP
cord-329363-kaw3h5xm	32	12	,	,	,
cord-329363-kaw3h5xm	32	13	University	University	NNP
cord-329363-kaw3h5xm	32	14	of	of	IN
cord-329363-kaw3h5xm	32	15	Minnesota	Minnesota	NNP
cord-329363-kaw3h5xm	32	16	Medical	Medical	NNP
cord-329363-kaw3h5xm	32	17	School	School	NNP
cord-329363-kaw3h5xm	32	18	,	,	,
cord-329363-kaw3h5xm	32	19	1	1	CD
cord-329363-kaw3h5xm	32	20	Veterans	Veterans	NNPS
cord-329363-kaw3h5xm	32	21	Way	Way	NNP
cord-329363-kaw3h5xm	32	22	,	,	,
cord-329363-kaw3h5xm	32	23	Minneapolis	Minneapolis	NNP
cord-329363-kaw3h5xm	32	24	,	,	,
cord-329363-kaw3h5xm	32	25	MN	MN	NNP
cord-329363-kaw3h5xm	32	26	55417	55417	CD
cord-329363-kaw3h5xm	32	27	.	.	.
cord-329363-kaw3h5xm	33	1	Email	email	NN
cord-329363-kaw3h5xm	33	2	ovar-deny@umn.edu	ovar-deny@umn.edu	NNP
cord-329363-kaw3h5xm	33	3	Acute	acute	JJ
cord-329363-kaw3h5xm	33	4	myocardial	myocardial	JJ
cord-329363-kaw3h5xm	33	5	infarction	infarction	NN
cord-329363-kaw3h5xm	33	6	after	after	IN
cord-329363-kaw3h5xm	33	7	laboratory	laboratory	NN
cord-329363-kaw3h5xm	33	8	-	-	HYPH
cord-329363-kaw3h5xm	33	9	confirmed	confirm	VBN
cord-329363-kaw3h5xm	33	10	influenza	influenza	NN
cord-329363-kaw3h5xm	33	11	infection	infection	NNP
cord-329363-kaw3h5xm	33	12	Association	Association	NNP
cord-329363-kaw3h5xm	33	13	of	of	IN
cord-329363-kaw3h5xm	33	14	influenzalike	influenzalike	NNP
cord-329363-kaw3h5xm	33	15	illness	illness	NN
cord-329363-kaw3h5xm	33	16	activity	activity	NN
cord-329363-kaw3h5xm	33	17	with	with	IN
cord-329363-kaw3h5xm	33	18	hospitalizations	hospitalization	NNS
cord-329363-kaw3h5xm	33	19	for	for	IN
cord-329363-kaw3h5xm	33	20	heart	heart	NN
cord-329363-kaw3h5xm	33	21	failure	failure	NN
cord-329363-kaw3h5xm	33	22	:	:	:
cord-329363-kaw3h5xm	33	23	the	the	DT
cord-329363-kaw3h5xm	33	24	Atherosclerosis	Atherosclerosis	NNP
cord-329363-kaw3h5xm	33	25	Risk	Risk	NNP
cord-329363-kaw3h5xm	33	26	in	in	IN
cord-329363-kaw3h5xm	33	27	Communities	Communities	NNP
cord-329363-kaw3h5xm	33	28	Study	Study	NNP
cord-329363-kaw3h5xm	33	29	Characteristics	Characteristics	NNPS
cord-329363-kaw3h5xm	33	30	of	of	IN
cord-329363-kaw3h5xm	33	31	and	and	CC
cord-329363-kaw3h5xm	33	32	important	important	JJ
cord-329363-kaw3h5xm	33	33	lessons	lesson	NNS
cord-329363-kaw3h5xm	33	34	from	from	IN
cord-329363-kaw3h5xm	33	35	the	the	DT
cord-329363-kaw3h5xm	33	36	coronavirus	coronavirus	NN
cord-329363-kaw3h5xm	33	37	disease	disease	NN
cord-329363-kaw3h5xm	33	38	2019	2019	CD
cord-329363-kaw3h5xm	33	39	(	(	-LRB-
cord-329363-kaw3h5xm	33	40	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	33	41	)	)	-RRB-
cord-329363-kaw3h5xm	33	42	outbreak	outbreak	NN
cord-329363-kaw3h5xm	33	43	in	in	IN
cord-329363-kaw3h5xm	33	44	China	China	NNP
cord-329363-kaw3h5xm	33	45	:	:	:
cord-329363-kaw3h5xm	33	46	summary	summary	NN
cord-329363-kaw3h5xm	33	47	of	of	IN
cord-329363-kaw3h5xm	33	48	a	a	DT
cord-329363-kaw3h5xm	33	49	report	report	NN
cord-329363-kaw3h5xm	33	50	of	of	IN
cord-329363-kaw3h5xm	33	51	72314	72314	CD
cord-329363-kaw3h5xm	33	52	cases	case	NNS
cord-329363-kaw3h5xm	33	53	from	from	IN
cord-329363-kaw3h5xm	33	54	the	the	DT
cord-329363-kaw3h5xm	33	55	Chinese	Chinese	NNP
cord-329363-kaw3h5xm	33	56	Center	Center	NNP
cord-329363-kaw3h5xm	33	57	for	for	IN
cord-329363-kaw3h5xm	33	58	Disease	Disease	NNP
cord-329363-kaw3h5xm	33	59	Control	Control	NNP
cord-329363-kaw3h5xm	33	60	and	and	CC
cord-329363-kaw3h5xm	33	61	Prevention	Prevention	NNP
cord-329363-kaw3h5xm	33	62	Coronavirus	Coronavirus	NNP
cord-329363-kaw3h5xm	33	63	disease	disease	NN
cord-329363-kaw3h5xm	33	64	2019	2019	CD
cord-329363-kaw3h5xm	34	1	(	(	-LRB-
cord-329363-kaw3h5xm	34	2	CO	co	NN
cord-329363-kaw3h5xm	34	3	-	-	NN
cord-329363-kaw3h5xm	34	4	VID-19	vid-19	ADD
cord-329363-kaw3h5xm	34	5	)	)	-RRB-
cord-329363-kaw3h5xm	35	1	and	and	CC
cord-329363-kaw3h5xm	35	2	cardiovascular	cardiovascular	JJ
cord-329363-kaw3h5xm	35	3	disease	disease	NN
cord-329363-kaw3h5xm	35	4	Estimating	estimate	VBG
cord-329363-kaw3h5xm	35	5	clinical	clinical	JJ
cord-329363-kaw3h5xm	35	6	severity	severity	NN
cord-329363-kaw3h5xm	35	7	of	of	IN
cord-329363-kaw3h5xm	35	8	COVID-19	COVID-19	NNP
cord-329363-kaw3h5xm	35	9	from	from	IN
cord-329363-kaw3h5xm	35	10	the	the	DT
cord-329363-kaw3h5xm	35	11	transmission	transmission	NN
cord-329363-kaw3h5xm	35	12	dynamics	dynamic	NNS
cord-329363-kaw3h5xm	35	13	in	in	IN
cord-329363-kaw3h5xm	35	14	Wuhan	Wuhan	NNP
cord-329363-kaw3h5xm	36	1	,	,	,
cord-329363-kaw3h5xm	36	2	China	China	NNP
cord-329363-kaw3h5xm	36	3	Dr	Dr	NNP
cord-329363-kaw3h5xm	36	4	Vardeny	Vardeny	NNP
cord-329363-kaw3h5xm	36	5	has	have	VBZ
cord-329363-kaw3h5xm	36	6	received	receive	VBN
cord-329363-kaw3h5xm	36	7	research	research	NN
cord-329363-kaw3h5xm	36	8	grants	grant	NNS
cord-329363-kaw3h5xm	36	9	from	from	IN
cord-329363-kaw3h5xm	36	10	the	the	DT
cord-329363-kaw3h5xm	36	11	US	US	NNP
cord-329363-kaw3h5xm	36	12	National	National	NNP
cord-329363-kaw3h5xm	36	13	Institutes	Institutes	NNPS
cord-329363-kaw3h5xm	36	14	of	of	IN
cord-329363-kaw3h5xm	36	15	Health	Health	NNP
cord-329363-kaw3h5xm	36	16	and	and	CC
cord-329363-kaw3h5xm	36	17	AstraZeneca	AstraZeneca	NNP
cord-329363-kaw3h5xm	36	18	and	and	CC
cord-329363-kaw3h5xm	36	19	has	have	VBZ
cord-329363-kaw3h5xm	36	20	consulted	consult	VBN
cord-329363-kaw3h5xm	36	21	for	for	IN
cord-329363-kaw3h5xm	36	22	Novartis	Novartis	NNP
cord-329363-kaw3h5xm	36	23	,	,	,
cord-329363-kaw3h5xm	36	24	Amgen	Amgen	NNP
cord-329363-kaw3h5xm	36	25	,	,	,
cord-329363-kaw3h5xm	36	26	and	and	CC
cord-329363-kaw3h5xm	36	27	Sanofi	Sanofi	NNP
cord-329363-kaw3h5xm	36	28	-	-	HYPH
cord-329363-kaw3h5xm	36	29	Pasteur	Pasteur	NNP
cord-329363-kaw3h5xm	36	30	.	.	.
cord-329363-kaw3h5xm	37	1	Dr	Dr	NNP
cord-329363-kaw3h5xm	37	2	Madjid	Madjid	NNP
cord-329363-kaw3h5xm	37	3	reports	report	VBZ
cord-329363-kaw3h5xm	37	4	serving	serve	VBG
cord-329363-kaw3h5xm	37	5	as	as	IN
cord-329363-kaw3h5xm	37	6	a	a	DT
cord-329363-kaw3h5xm	37	7	speaker	speaker	NN
cord-329363-kaw3h5xm	37	8	and	and	CC
cord-329363-kaw3h5xm	37	9	consultant	consultant	NN
cord-329363-kaw3h5xm	37	10	for	for	IN
cord-329363-kaw3h5xm	37	11	Sanofi	Sanofi	NNP
cord-329363-kaw3h5xm	37	12	-	-	HYPH
cord-329363-kaw3h5xm	37	13	Pasteur	Pasteur	NNP
cord-329363-kaw3h5xm	37	14	.	.	.
cord-329363-kaw3h5xm	38	1	Dr	Dr	NNP
cord-329363-kaw3h5xm	38	2	Solomon	Solomon	NNP
cord-329363-kaw3h5xm	38	3	has	have	VBZ
cord-329363-kaw3h5xm	38	4	received	receive	VBN
cord-329363-kaw3h5xm	38	5	research	research	NN
cord-329363-kaw3h5xm	38	6	grants	grant	NNS
cord-329363-kaw3h5xm	38	7	from	from	IN
cord-329363-kaw3h5xm	38	8	Alnylam	Alnylam	NNP
cord-329363-kaw3h5xm	38	9	,	,	,
cord-329363-kaw3h5xm	38	10	Amgen	Amgen	NNP
cord-329363-kaw3h5xm	38	11	,	,	,
cord-329363-kaw3h5xm	38	12	AstraZeneca	AstraZeneca	NNP
cord-329363-kaw3h5xm	38	13	,	,	,
cord-329363-kaw3h5xm	38	14	Bellerophon	Bellerophon	NNP
cord-329363-kaw3h5xm	38	15	,	,	,
cord-329363-kaw3h5xm	38	16	Bayer	Bayer	NNP
cord-329363-kaw3h5xm	38	17	,	,	,
cord-329363-kaw3h5xm	38	18	BMS	BMS	NNP
cord-329363-kaw3h5xm	38	19	,	,	,
cord-329363-kaw3h5xm	38	20	Celladon	Celladon	NNP
cord-329363-kaw3h5xm	38	21	,	,	,
cord-329363-kaw3h5xm	38	22	Cytokinetics	Cytokinetics	NNP
cord-329363-kaw3h5xm	38	23	,	,	,
cord-329363-kaw3h5xm	38	24	Eidos	Eidos	NNP
cord-329363-kaw3h5xm	38	25	,	,	,
cord-329363-kaw3h5xm	38	26	Gilead	Gilead	NNP
cord-329363-kaw3h5xm	38	27	,	,	,
cord-329363-kaw3h5xm	38	28	GlaxoSmithKline	GlaxoSmithKline	NNP
cord-329363-kaw3h5xm	38	29	,	,	,
cord-329363-kaw3h5xm	38	30	Ionis	Ionis	NNP
cord-329363-kaw3h5xm	38	31	,	,	,
cord-329363-kaw3h5xm	38	32	Lone	Lone	NNP
cord-329363-kaw3h5xm	38	33	Star	Star	NNP
cord-329363-kaw3h5xm	38	34	Heart	Heart	NNP
cord-329363-kaw3h5xm	38	35	,	,	,
cord-329363-kaw3h5xm	38	36	Mesoblast	Mesoblast	NNP
cord-329363-kaw3h5xm	38	37	,	,	,
cord-329363-kaw3h5xm	38	38	MyoKardia	MyoKardia	NNP
cord-329363-kaw3h5xm	38	39	,	,	,
cord-329363-kaw3h5xm	38	40	National	National	NNP
cord-329363-kaw3h5xm	38	41	Institutes	Institutes	NNPS
cord-329363-kaw3h5xm	38	42	of	of	IN
cord-329363-kaw3h5xm	38	43	Health	Health	NNP
cord-329363-kaw3h5xm	38	44	/	/	SYM
cord-329363-kaw3h5xm	38	45	National	National	NNP
cord-329363-kaw3h5xm	38	46	Heart	Heart	NNP
cord-329363-kaw3h5xm	38	47	,	,	,
cord-329363-kaw3h5xm	38	48	Lung	Lung	NNP
cord-329363-kaw3h5xm	38	49	,	,	,
cord-329363-kaw3h5xm	38	50	and	and	CC
cord-329363-kaw3h5xm	38	51	Blood	Blood	NNP
cord-329363-kaw3h5xm	38	52	Institute	Institute	NNP
cord-329363-kaw3h5xm	38	53	,	,	,
cord-329363-kaw3h5xm	38	54	Novartis	Novartis	NNP
cord-329363-kaw3h5xm	38	55	,	,	,
cord-329363-kaw3h5xm	38	56	Sanofi	Sanofi	NNP
cord-329363-kaw3h5xm	38	57	Pasteur	Pasteur	NNP
cord-329363-kaw3h5xm	38	58	,	,	,
cord-329363-kaw3h5xm	38	59	and	and	CC
cord-329363-kaw3h5xm	38	60	Theracos	Theracos	NNP
cord-329363-kaw3h5xm	38	61	;	;	:
cord-329363-kaw3h5xm	38	62	and	and	CC
cord-329363-kaw3h5xm	38	63	has	have	VBZ
cord-329363-kaw3h5xm	38	64	consulted	consult	VBN
cord-329363-kaw3h5xm	38	65	for	for	IN
cord-329363-kaw3h5xm	38	66	Akros	Akros	NNP
cord-329363-kaw3h5xm	38	67	,	,	,
cord-329363-kaw3h5xm	38	68	Alnylam	Alnylam	NNP
cord-329363-kaw3h5xm	38	69	,	,	,
cord-329363-kaw3h5xm	38	70	Amgen	Amgen	NNP
cord-329363-kaw3h5xm	38	71	,	,	,
cord-329363-kaw3h5xm	38	72	Arena	Arena	NNP
cord-329363-kaw3h5xm	38	73	,	,	,
cord-329363-kaw3h5xm	38	74	AstraZeneca	AstraZeneca	NNP
cord-329363-kaw3h5xm	38	75	,	,	,
cord-329363-kaw3h5xm	38	76	Bayer	Bayer	NNP
cord-329363-kaw3h5xm	38	77	,	,	,
cord-329363-kaw3h5xm	38	78	Bristol	Bristol	NNP
cord-329363-kaw3h5xm	38	79	-	-	HYPH
cord-329363-kaw3h5xm	38	80	Myers	Myers	NNP
cord-329363-kaw3h5xm	38	81	Squibb	Squibb	NNP
cord-329363-kaw3h5xm	38	82	,	,	,
cord-329363-kaw3h5xm	38	83	Cardior	Cardior	NNP
cord-329363-kaw3h5xm	38	84	,	,	,
cord-329363-kaw3h5xm	38	85	Cardurion	Cardurion	NNP
cord-329363-kaw3h5xm	38	86	,	,	,
cord-329363-kaw3h5xm	38	87	Corvia	Corvia	NNP
cord-329363-kaw3h5xm	38	88	,	,	,
cord-329363-kaw3h5xm	38	89	Cytokinetics	Cytokinetics	NNP
cord-329363-kaw3h5xm	38	90	,	,	,
cord-329363-kaw3h5xm	38	91	Daiichi	Daiichi	NNP
cord-329363-kaw3h5xm	38	92	-	-	HYPH
cord-329363-kaw3h5xm	38	93	Sankyo	Sankyo	NNP
cord-329363-kaw3h5xm	38	94	,	,	,
cord-329363-kaw3h5xm	38	95	Gilead	Gilead	NNP
cord-329363-kaw3h5xm	38	96	,	,	,
cord-329363-kaw3h5xm	38	97	GlaxoSmithKline	GlaxoSmithKline	NNP
cord-329363-kaw3h5xm	38	98	,	,	,
cord-329363-kaw3h5xm	38	99	Ironwood	Ironwood	NNP
cord-329363-kaw3h5xm	38	100	,	,	,
cord-329363-kaw3h5xm	38	101	Merck	Merck	NNP
cord-329363-kaw3h5xm	38	102	,	,	,
cord-329363-kaw3h5xm	38	103	MyoKardia	MyoKardia	NNP
cord-329363-kaw3h5xm	38	104	,	,	,
cord-329363-kaw3h5xm	38	105	Novartis	Novartis	NNP
cord-329363-kaw3h5xm	38	106	,	,	,
cord-329363-kaw3h5xm	38	107	Roche	Roche	NNP
cord-329363-kaw3h5xm	38	108	,	,	,
cord-329363-kaw3h5xm	38	109	Sanofi	Sanofi	NNP
cord-329363-kaw3h5xm	38	110	-	-	HYPH
cord-329363-kaw3h5xm	38	111	Pasteur	Pasteur	NNP
cord-329363-kaw3h5xm	38	112	,	,	,
cord-329363-kaw3h5xm	38	113	Takeda	Takeda	NNP
cord-329363-kaw3h5xm	38	114	,	,	,
cord-329363-kaw3h5xm	38	115	Theracos	Theracos	NNP
cord-329363-kaw3h5xm	38	116	,	,	,
cord-329363-kaw3h5xm	38	117	Quantum	Quantum	NNP
cord-329363-kaw3h5xm	38	118	Genetics	Genetics	NNP
cord-329363-kaw3h5xm	38	119	,	,	,
cord-329363-kaw3h5xm	38	120	Cardurion	Cardurion	NNP
cord-329363-kaw3h5xm	38	121	,	,	,
cord-329363-kaw3h5xm	38	122	AoBiome	AoBiome	NNP
cord-329363-kaw3h5xm	38	123	,	,	,
cord-329363-kaw3h5xm	38	124	Janssen	Janssen	NNP
cord-329363-kaw3h5xm	38	125	,	,	,
cord-329363-kaw3h5xm	38	126	Cardiac	Cardiac	NNP
cord-329363-kaw3h5xm	38	127	Dimensions	Dimensions	NNPS
cord-329363-kaw3h5xm	38	128	,	,	,
cord-329363-kaw3h5xm	38	129	Tenaya	Tenaya	NNP
cord-329363-kaw3h5xm	38	130	,	,	,
cord-329363-kaw3h5xm	38	131	Dinaqor	Dinaqor	NNP
cord-329363-kaw3h5xm	38	132	,	,	,
cord-329363-kaw3h5xm	38	133	and	and	CC
cord-329363-kaw3h5xm	38	134	Tremeau	Tremeau	NNP
cord-329363-kaw3h5xm	38	135	.	.	.